Companies: 10,795·Total market cap: $144.5T
Bellevue Life Sciences Acquisition Corp.

Bellevue Life Sciences Acquisition Corp.

BLACNASDAQFinancial Services
$3.01
$-3.72(-55.27%)
Market Cap$6982448
P/E Ratio
52W High$13.4
52W Low$3.01
Overview

Bellevue Life Sciences Acquisition Corp. (BLAC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BLAC · as of Jun 8, 2026

Key Statistics

EPS (TTM)$2.45blac eps ttm · blac earnings per shareEarnings history
PE Ratio (TTM)1.2×blac pe ratio ttm · blac price to earningsPE Ratio deep dive
Revenue (TTM)$2.6Mblac revenue ttm · blac annual revenueFull revenue history
Dividend YieldNo Dividenddoes blac pay dividends · blac dividend yieldDividend history
Shares Outstandingblac shares outstanding · blac floatShares outstanding history
Next EarningsTBAblac earnings date · blac next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$2.9M
202320242025
bellevue life sciences acquisition corp. revenue · blac revenue 2025
FY 2025Net Income-$28.9M▼ 1098.19% YoY
202320242025
bellevue life sciences acquisition corp. net income · blac profit 2025
FY 2025EPS$0.00▲ +100.00% YoY
202320242025
blac eps · bellevue life sciences acquisition corp. earnings per share 2025
TTM:Revenue: $2.6MNet Income: $7.9MEPS: $2.45View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M-73.27%
YTD-73.89%
1Y-71.74%
5Y-70.20%

About Bellevue Life Sciences Acquisition Corp.

CEOKuk Hyoun Hwang
IPO DateMar 21, 2023
Employees
CountryUS

Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, s…

what is bellevue life sciences acquisition corp. · blac stock overview · bellevue life sciences acquisition corp. company profile · who is bellevue life sciences acquisition corp. ceo · blac NASDAQ · bellevue life sciences acquisition corp. headquarters · bellevue life sciences acquisition corp. business segments

About Stock Overview & Key Data

Bellevue Life Sciences Acquisition Corp. (BLAC) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Mar 21, 2023. As of the latest trading session, BLAC stock price is $3.01, with a market capitalization of $7.0M. The stock has returned -71.74% over the past 12 months and -73.89% year-to-date.

In fiscal year 2025, Bellevue Life Sciences Acquisition Corp. reported revenue of $2.9M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Bellevue Life Sciences Acquisition Corp. (BLAC) stock price is $3.01. The stock is traded on NASDAQ under the ticker symbol BLAC. The 52-week range is $3.01 – $13.40.

BLAC stock priceBLAC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice